Table 1.
Clinical characteristics
Characteristic | ESRD n=68 (22.1%) |
No ESRD n=239 (77.9%) |
P value |
Age (years) | 54.9±16.5 | 35.6±14.1 | <0.001 |
Sex, (n) % | 0.02 | ||
Female | 45 (66) | 121 (51) | |
Male | 23 (34) | 118 (49) | |
Body mass index (kg/m2) | 27.8±8.3 | 27.1±7.3 | 0.43 |
Race, (n) % | 0.88 | ||
Caucasian | 18 (26) | 59 (25) | |
African-American | 48 (71) | 168 (70) | |
Others | 2 (3) | 12 (5) | |
Ethnicity, (n) % | 0.61 | ||
Hispanic | 1 (1) | 9 (4) | |
Non-Hispanic | 60 (88) | 198 (83) | |
Not reported | 7 (10) | 32 (13) | |
Insurance, (n) % | <0.001 | ||
Commercial | 15 (22) | 88 (37) | |
Government (Medicare/Medicaid) | 50 (74) | 68 (29) | |
No insurance | 3 (4) | 82 (34) | |
Comorbidities, n (%) | |||
Coronary artery disease | 14 (21) | 7 (3) | <0.001 |
Hyperlipidemia | 22 (32) | 34 (14) | <0.001 |
Chronic obstructive pulmonary disease | 8 (12) | 12 (5) | 0.06 |
Peripheral vascular disease | 6 (9) | 1 (0.4) | <0.001 |
Acute pancreatitis | 2 (3) | 10 (4) | >0.99 |
Homelessness | 0 | 9 (4) | 0.22 |
Depression | 10 (15) | 27 (11) | 0.53 |
Substance abuse | 2 (3) | 18 (8) | 0.27 |
Data presented as mean±(SD) or count (percentage), unless otherwise indicated.
ESRD, end-stage renal disease.